1. Ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in prostate cancer patients: influence of Gleason score, treatment and bone metastasis.
- Author
-
Battisti V, Maders LD, Bagatini MD, Battisti IE, Bellé LP, Santos KF, Maldonado PA, Thomé GR, Schetinger MR, and Morsch VM
- Subjects
- Aged, Aged, 80 and over, Biomarkers, Tumor metabolism, Bone Neoplasms secondary, Bone Neoplasms therapy, Down-Regulation physiology, Female, Humans, Male, Middle Aged, Neoplasm Grading, Phosphoric Diester Hydrolases blood, Prostatic Neoplasms therapy, Pyrophosphatases blood, Treatment Outcome, Adenosine Deaminase metabolism, Bone Neoplasms enzymology, Bone Neoplasms pathology, Phosphoric Diester Hydrolases metabolism, Prostatic Neoplasms enzymology, Prostatic Neoplasms pathology, Pyrophosphatases metabolism
- Abstract
The relation between adenine nucleotides and cancer has already been described in literature. Considering that the enzymes ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) act together to control nucleotide levels, we aimed to investigate the role of these enzymes in prostate cancer (PCa). E-NPP and ADA activities were determined in serum and platelets of PCa patients and controls. We also verified the influence of the Gleason score, bone metastasis and treatment in the enzyme activities. Platelets and serum E-NPP activity increased, whereas ADA activity in serum decreased in PCa patients. In addition, Gleason score, metastasis and treatment influenced E-NPP and ADA activities. We may propose that E-NPP and ADA are involved in the development of PCa. Moreover, E-NPP and ADA activities are modified in PCa patients with distinct Gleason score, with bone metastasis, as well as in patients under treatment., (Copyright © 2013 Elsevier Masson SAS. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF